
Another analyst taps the sign
Bank of New York Mellon got another friendly nudge from Wall Street on April 17, when Truist Securities’ David Smith kept the stock at Buy and raised the price target to $148 from $140. That’s not exactly a plot twist, but it is another “we still like this one” stamp on a name that’s been attracting a lot of analyst attention lately.
Why you should care
For BK, price-target raises matter because this is a giant, steady, finance-y machine that investors often treat like a bond proxy with better branding. When analysts keep pushing targets higher, it can help support the stock’s momentum — especially when the story is less about flashy growth and more about durability, capital returns, and how nicely the bank manages its money pile.
The Street keeps circling BK
This update lands in the middle of a busy stretch for BNY Mellon, with multiple analysts already chiming in on the name. So if you’re watching BK, the message from the Street is basically: this isn’t a one-off compliment, it’s a chorus.
- Truist: Buy, target up to $148
- Recent analyst chatter: still broadly constructive
- Investor takeaway: BK remains very much on the radar as a quality, shareholder-return story
Big picture: BK may not be the flashiest stock in the casino, but it’s getting treated like a dependable house favorite — and the Street keeps betting the chips are still on the table.
